Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
Immunogenic cell death (ICD) is a powerful trigger eliciting strong immune responses against tumors. However, traditional chemoimmunotherapy (CIT) does not last long enough to induce sufficient ICD, and also does not guarantee the safety of chemotherapeutics. To overcome the disadvantages of the con...
Saved in:
Main Authors: | Jeongrae Kim (Author), Yongwhan Choi (Author), Suah Yang (Author), Jaewan Lee (Author), Jiwoong Choi (Author), Yujeong Moon (Author), Jinseong Kim (Author), Nayeon Shim (Author), Hanhee Cho (Author), Man Kyu Shim (Author), Sangmin Jeon (Author), Dong-Kwon Lim (Author), Hong Yeol Yoon (Author), Kwangmeyung Kim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
by: Yongwhan Choi, et al.
Published: (2020) -
Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
by: Hanhee Cho, et al.
Published: (2021) -
Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy
by: Youngjoo Lee, et al.
Published: (2024) -
Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound
by: Yongwhan Choi, et al.
Published: (2020) -
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
by: Hanhee Cho, et al.
Published: (2022)